中文产业新闻精选评分68Chinese source
武田Zasocitinib（TAK-279）银屑病NDA获FDA受理并获优先审评
60 亿美元引进！武田银屑病新药申报上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
60 亿美元引进！武田银屑病新药申报上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.